HOME >> BIOLOGY >> NEWS
NHGRI adds cow and dog to high priority list for sequencing model organisms

BETHESDA, Md., Sept. 11, 2002 The National Advisory Council for Human Genome Research has recommended adding the cow, the dog and the ciliate Oxytricha to the high-priority list of model organisms that should be considered for genome sequencing as capacity becomes available. Cow and dog join a growing group of high priority animals that includes chimpanzee, chicken and honeybee. Sequencing projects on the human, mouse and rat genomes are progressing rapidly, making sequencing capability supported by the National Human Genome Research Institute (NHGRI) available soon for work on other organisms.

"The priority list is based on medical and biological opportunities," said NHGRI Director Francis S. Collins, M.D., Ph.D. "But it is not yet a commitment to sequence the genomes of these organisms."

Sequencing the cow, along with the honeybee and the chicken, is expected to speed up studies of these agriculturally important animals. The proposal to sequence the cow was submitted by researchers at Baylor College of Medicine, the U.S. Department of Agriculture's U.S. Meat Animal Research Center, the University of Illinois and Texas A&M University.

"I am delighted that NIH has decided to give high priority to sequencing the bovine genome," said Joseph Jen, Under Secretary, Research, Education, and Economics, U.S. Department of Agriculture. "Sequencing the bovine genes will help in the development of meat and dairy products that consumers want while maintaining and increasing the safety of our food supply. USDA looks forward to participating in the research."

The proposal to sequence the dog was submitted by researchers at the Fred Hutchinson Cancer Research Center in Seattle, Wash., the Whitehead/MIT Center for Genome Research, Cambridge, Mass., and the Canine Genome Mapping Community, including researchers from a wide range of universities and institutions. The dog genome is expected to have medical benefits since dogs suffer many of the same di
'"/>

Contact: Geoff Spencer
301-402-0911
NIH/National Human Genome Research Institute
12-Sep-2002


Page: 1 2 3 4

Related biology news :

1. NHGRI launches Centers for Excellence in Ethical, Legal, and Social Implications Research
2. NHGRI adds 18 organisms to sequencing pipeline
3. NHGRI selects sequencing centers
4. NHGRI study may help scientists develop safer methods for gene therapy
5. NHGRI funds two new centers of excellence in genomic science
6. NHGRI launches genome.gov
7. NHGRI prioritizes model organisms for sequencing
8. Whitehead Receives $35 Million Grant From National Human Genome Research Institute (NHGRI)
9. Borneo elephants: A high priority for conservation
10. DFG to establish 14 new priority programmes
11. DFG to launch 21 new priority programmes

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: NHGRI adds cow and dog high priority list for sequencing model organisms

(Date:12/17/2014)... 2014  Automation is fundamentally transforming the travel ... at international borders. Over the past decade, ePassports, ... veteran travelers to self process through border control ... at an increasing number of airports, seaports, and ... According to Maxine Most , Principal at ...
(Date:12/11/2014)... WINSTON SALEM, N.C. , Dec. 10, 2014  That ... known for quite a while. Hypertension – the medical term ... disease in the early 1800s, and the inflatable cuff that,s ... That doesn,t, however, mean there,s nothing new about hypertension, ... punctured some long-held beliefs about the condition and the best ...
(Date:12/10/2014)... N.C. , Dec. 9, 2014  Wake Forest Baptist ... education building for its School of Medicine. Funding for ... larger capital campaign that will be publicly launched next ... be located in the former 60 series R.J. Reynolds ... Innovation Quarter. Construction will begin immediately with plans to ...
Breaking Biology News(10 mins):Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
(Date:12/17/2014)... SOUTH SAN FRANCISCO, Calif. , Dec. 17, ... positive results of a Phase 2 study evaluating ... for the treatment of patients with severe, chronic ... the current standard of care, including topical steroids ... endpoint was percent change in Visual Analog Scale ...
(Date:12/15/2014)...  GlassesOff Inc. (OTCBB: GLSO) announced today the appointment ... director of the Company,s Board of Directors. ... its CEO until its acquisition by Stanley Black ... Recognized as the inventor of the first Wi-Fi-based Active ... -based RFID solutions focused on improving operational efficiency, safety ...
(Date:12/13/2014)... (PRWEB) December 12, 2014 Clarassance, a ... announced its new name: Therabron Therapeutics , Inc. ... and bronchioles (a type of structure in the lungs ... company’s mission to develop novel protein therapeutics for the ... directors decided to change the name to mark the ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
Cached News: